Personalized Pathology & Cancer Therapy
41 – 50 of 80
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Stromal progesterone receptor expression and long-term survival in patients with resected periampullary adenocarcinoma
2018) In Annals of oncology : official journal of the European Society for Medical Oncology 29(Suppl. 8). p.262-263(
- Contribution to journal › Published meeting abstract
-
Mark
Pre-diagnostic anthropometry, sex, and risk of colorectal cancer according to tumor-infiltrating immune cell composition
2018) In Annals of oncology : official journal of the European Society for Medical Oncology 29(Suppl. 8). p.180-180(
- Contribution to journal › Published meeting abstract
-
Mark
Discovery of KIRREL as a biomarker for prognostic stratification of patients with thin melanoma
2018) In Annals of oncology : official journal of the European Society for Medical Oncology 29(Suppl. 8). p.463-463(
- Contribution to journal › Published meeting abstract
-
Mark
Prognostic significance of lymphocyte-activation gene-3 expression in chemoradiotherapy-naïve esophageal and gastric adenocarcinoma
2018) In Annals of oncology : official journal of the European Society for Medical Oncology 29(Suppl. 8). p.220-220(
- Contribution to journal › Published meeting abstract
-
Mark
Analytical validation of OncoMasTR, a multigene test for predicting risk of distant recurrence in hormone receptor-positive early stage breast cancer
2018) In Annals of oncology : official journal of the European Society for Medical Oncology 29(Suppl. 8). p.65-65(
- Contribution to journal › Published meeting abstract
- 2017
-
Mark
Body mass index influences the prognostic impact of combined nuclear insulin receptor and estrogen receptor expression in primary breast cancer
(
- Contribution to journal › Article
-
Mark
Infiltration of γδ T cells, IL-17 + T cells and FoxP3 + T cells in human breast cancer
(
- Contribution to journal › Article
-
Mark
Androgen Receptor in Stage I-II Primary Breast Cancer -Prognostic Value and Distribution in Subgroups
(
- Contribution to journal › Article
-
Mark
High RBM3 expression is associated with an improved survival and oxaliplatin response in patients with metastatic colorectal cancer
(
- Contribution to journal › Article
-
Mark
Reaching the limits of prognostication in non-small cell lung cancer : an optimized biomarker panel fails to outperform clinical parameters
(
- Contribution to journal › Article